Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 3/20 | 0.54 |
| ▸ | PPARD | Q03181 | 2/20 | 0.54 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.51 |
| ▸ | PPARA | Q07869 | 1/20 | 0.51 |
| ▸ | SOD1 | P00441 | 1/20 | 0.51 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.50 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.50 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.50 |
| ▸ | CD69 | Q07108 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA4 | P22748 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30831879 | 1.00 | SMN1; SMN2 (0.65) | SMN1; SMN2LMNAFFAR1ALOX15CYP2C19 | |
| SCHEMBL18120698 | 0.87 | SOD1 (0.51) | SMN1; SMN2LMNAFFAR1CYP2C19PPARG | |
| SCHEMBL14065575 | 0.85 | KDM4E (0.51) | SMN1; SMN2LMNAFFAR1PPARGPPARD | |
| SCHEMBL18231441 | 0.84 | LMNA (0.56) | SMN1; SMN2LMNAFFAR1ALOX15PPARG | |
| SCHEMBL12993061 | 0.84 | ALDH1A1 (0.51) | SMN1; SMN2LMNAFFAR1CYP2C19PPARG | |
| SCHEMBL31645913 | 0.83 | KDM4E (0.68) | LMNAALOX15PPARGPTPN7PPARA | |
| SCHEMBL585546 | 0.83 | KDM4E (0.68) | LMNAALOX15PPARGPTPN7PPARA | |
| SCHEMBL3261362 | 0.83 | LMNA (0.55) | SMN1; SMN2LMNAFFAR1ALOX15PPARG | |
| SCHEMBL12082548 | 0.83 | SYK (0.58) | FFAR1CYP2C19PPARGPPARDSOD1 | |
| SCHEMBL4403419 | 0.83 | SMN1; SMN2 (0.55) | SMN1; SMN2FFAR1PPARGPPARDSOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112955012-B | Compositions comprising pyridine carboxylic acid herbicides and plant growth regulators | 科迪华农业科技有限责任公司 | 2023-05-23 | — | — | CN | claimed |
| EP-2548434-B1 | New tree | BVBA CAROLUS C (BE) | 2017-12-06 | — | — | EP | claimed |
| EP-2548433-B1 | Nursery fruit tree | BVBA CAROLUS C (BE) | 2016-02-17 | — | — | EP | claimed |
| US-20140005049-A1 | ACTIVE COMPOUND COMBINATIONS | ILG KERSTIN (DE) | 2014-01-02 | — | — | US | claimed |
| EP-2548434-A1 | New tree | BVBA Carolus C. (BE) | 2013-01-23 | — | — | EP | claimed |
| EP-2548433-A1 | Nursery fruit tree | BVBA Carolus C. (BE) | 2013-01-23 | — | — | EP | claimed |
| US-20110152077-A1 | Active compound combinations | BAYER CROPSCIENCE AG (DE) | 2011-06-23 | — | — | US | claimed |
| JP-58203902-A | — | — | None | — | — | JP | disclosed |
| CN-117813004-A | Auxin herbicide and application method thereof | 科迪华农业科技有限责任公司 | 2024-04-02 | — | — | CN | disclosed |
| EP-3456178-B1 | NURSERY FRUIT TREE OF AT LEAST DOUBLE TRUNK TYPE | GRADILIS RECH SARL (FR) | 2024-03-13 | — | — | EP | disclosed |
| CN-112955012-B | Compositions comprising pyridine carboxylic acid herbicides and plant growth regulators | 科迪华农业科技有限责任公司 | 2023-05-23 | — | — | CN | disclosed |
| US-20200275612-A1 | NURSERY FRUIT TREE OF AT LEAST DOUBLE TRUNK TYPE | GRADILIS RECHERCHE SARL (FR) | 2020-09-03 | — | — | US | disclosed |
| US-10246413-B2 | Selective FKBP51 ligands for treatment of psychiatric disorders | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2019-04-02 | — | — | US | disclosed |
| US-20070191371-A1 | HETEROCYCLIC MODULATORS OF PPAR | KALYPSYS, INC. (US) | 2007-08-16 | — | — | US | disclosed |
| US-7169936-B2 | Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2007-01-30 | — | — | US | disclosed |
| US-20070004757-A1 | INDOLINE DERIVATIVES SUBSTITUTED IN THE 6 POSITION, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | ROTH GERALD J | 2007-01-04 | — | — | US | disclosed |
| EP-0257063-A4 | COMPOSITIONS COMPRISING 1-SUBSTITUTED AZACYCLOALKANES AND THEIR USES. | NELSON RES & DEV COMPANY (US) | 1989-04-24 | — | — | EP | disclosed |
| EP-0257063-A1 | COMPOSITIONS COMPRISING 1-SUBSTITUTED AZACYCLOALKANES AND THEIR USES. | NELSON RES & DEV (US) | 1988-03-02 | — | — | EP | disclosed |
| WO-1987004706-A1 | COMPOSITIONS COMPRISING 1-SUBSTITUTED AZACYCLOALKANES AND THEIR USES | NELSON RESEARCH AND DEVELOPMENT COMPANY (US) | 1987-08-13 | — | — | WO | disclosed |
| JP-S58203902-A | PROMOTOR FOR OCCURRENCE OF SIDE BRANCH OF MULBERRY | FUJISAWA PHARMACEUT CO LTD | 1983-11-28 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191371-A1 | HETEROCYCLIC MODULATORS OF PPAR | PPARG, PPARD, PPARA | SMN1; SMN2 4609/4885LMNA 2210/4885FFAR1 38/4885 |
| US-20070004757-A1 | INDOLINE DERIVATIVES SUBSTITUTED IN THE 6 POSITION, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | KDR, FLT1, EGFR | SMN1; SMN2 4443/4885LMNA 2104/4885FFAR1 1282/4885 |
| US-20110152077-A1 | Active compound combinations | BROX, ATL3, AKR7A2 | SMN1; SMN2 2960/4885LMNA 2189/4885FFAR1 3037/4885 |
| US-10246413-B2 | Selective FKBP51 ligands for treatment of psychiatric disorders | FKBP5, FKBP1A, FKBP3 | SMN1; SMN2 792/4885LMNA 4560/4885FFAR1 1729/4885 |
| US-20140005049-A1 | ACTIVE COMPOUND COMBINATIONS | BROX, ATL3, AKR7A2 | SMN1; SMN2 2960/4885LMNA 2189/4885FFAR1 3037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.